BriaCell Therapeutics Corp. (NASDAQ:BCTX – Get Rating) – Research analysts at Zacks Small Cap decreased their FY2023 earnings per share (EPS) estimates for shares of BriaCell Therapeutics in a research report issued on Thursday, April 27th. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will earn ($1.57) per share for the year, […]